What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have found a way to do just that—by tweaking a key molecule in the vaccine’s delivery system. Using a century-old chemical trick called the Mannich reaction, they added anti-inflammatory phenol groups to the lipids that carry mRNA into cells. The result? A new class of lipids that reduce side effects, boost gene-editing success, fight cancer more effectively, and supercharge vaccines like those for COVID-19. This breakthrough could change how we build the next generation of vaccines and therapies.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Breakthrough sepsis drug shows promise in human trial
- A 20-year-old cancer vaccine may hold the key to long-term survival
- Tea can improve your health and longevity, but how you drink it matters
- Scientists may have been wrong about what causes asthma
- Why chronic gut inflammation can turn into colon cancer
- A hidden immune loop may drive dangerous inflammation with age
- Scientists solve a major roadblock holding back cancer cell therapy
- Vitamin A may be helping cancer hide from the immune system
- This sweet fruit is packed with hidden health compounds
- Scientists Found a Way to Supercharge the Immune System Against Cancer
